Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Adalimumab/etanercept/infliximab

Psoriasis or psoriasis reactivation: 15 case reports

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

    REFERENCE

    1. 1.

      Wendling D, Balblanc J, Briançon D, Brousse A, Lohse A, Deprez P, Aubin F.Psoriasis occurrence or reactivation under anti TNF therapy. A case series. 2008 Annual European Congress of Rheumatology: abstr. AB0695, 11 Jun 2008. Available from: URL: http://www.eular.org - France

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Adalimumab/etanercept/infliximab. React. Wkly. 1210, 6 (2008). https://doi.org/10.2165/00128415-200812100-00015

    Download citation

    Keywords

    • Rheumatoid Arthritis
    • Arthritis
    • Psoriasis
    • Infliximab
    • Etanercept